Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: press release (3)
heltzen
press release
investor
press clippings
video
ARCHIVE
podcast
ARCHIVE: Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything'
May 16, 2025
press release
investor
ARCHIVE
ARCHIVE: eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today
May 12, 2025
press release
investor
ARCHIVE
ARCHIVE: eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST
May 7, 2025
press release
investor
nutraceuticals
medicine
science
ARCHIVE
ARCHIVE: eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
May 6, 2025
press release
investor
video
science
ARCHIVE
korman
ARCHIVE: GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymes
April 21, 2025
press release
investor
science
ARCHIVE
korman
ARCHIVE: BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
April 10, 2025
talent
press release
investor
video
ARCHIVE
perriman
ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
April 2, 2025
press release
investor
ARCHIVE
ARCHIVE: eXoZymes Provides Fourth Quarter and Full Year 2024 Update
April 2, 2025
press release
IPO
investor
ARCHIVE
ARCHIVE: eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
March 26, 2025
press release
investor
ARCHIVE
ARCHIVE: eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
February 21, 2025
Previous page
Page 3 of 5
Next page